'%2F%3E%3Cpath%20d%3D'M6.5%2025%2016%207%2025.5%2025'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'3.8'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Ccircle%20cx%3D'16'%20cy%3D'19'%20r%3D'3.2'%20fill%3D'%23fff'%2F%3E%3C%2Fsvg%3E){kind=small}
ZENOTECH LABORATORIES LTD.
ZENOTECH (BSE 532039) · ISIN INE486F01012 · Pharmaceuticals · Est. 1989 · listed 1996 · website
Not on any surveillance list
In Q2 FY27 (quarter to 30 September 2026, standalone), revenue was ₹6.13 cr and profit after tax −₹2.57 cr. Revenue was 40.1% lower than in Q2 FY26.
Quarterly results
| Quarter | Revenue | Profit after tax | EPS (₹) | Filed |
|---|---|---|---|---|
| Q2 FY27 standalone | ₹6.13 cr | −₹2.57 cr | −0.42 | 28 Oct 2026 |
| Q1 FY27 standalone | ₹9.6 cr | −₹0.46 cr | −0.07 | 28 Jul 2026 |
| Q4 FY26 standalone | ₹8.87 cr | −₹3.15 cr | −0.52 | 29 Apr 2026 |
| Q3 FY26 standalone | ₹11.83 cr | ₹1.93 cr | 0.32 | 23 Jan 2026 |
| Q2 FY26 standalone | ₹10.23 cr | −₹0.84 cr | 0.14 | 31 Oct 2025 |
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹95.12 cr | ₹0 cr | ₹111.15 cr |
| 30 Sep 2025 standalone | ₹96.27 cr | ₹0 cr | ₹110.92 cr |
| 31 Mar 2025 standalone | ₹96.13 cr | ₹0 cr | ₹111.03 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 68.84% | — | 0.01% | 31.16% |
Latest filings
- Submission of Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026. 28 October 2026 · BSE
- Approval for Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026. 28 October 2026 · BSE
- Voting Results and Scrutinizer Report of 37th Annual General Meeting of the Company held on September 25, 2026. 26 September 2026 · BSE
- Outcome of the 37th Annual General Meeting of the Company held on Friday, September 25, 2026. 25 September 2026 · BSE
- Notice of 37th Annual General Meeting along with Annual Report for the FY 2025-26 28 August 2026 · BSE
Other companies in Pharmaceuticals
- Sun Pharmaceutical Industries Limited
- Lupin Limited
- Cipla Limited
- Dr. Reddy's Laboratories Limited
- Torrent Pharmaceuticals Limited
- Zydus Lifesciences Limited
- Mankind Pharma Limited
- Aurobindo Pharma Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 29 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.